Aller au contenu principal
2026 article

1350-P: Impact of Glycemia, Sleep, Physical Activity on Hypoglycemia Counterregulation in Type 1 Diabetes

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

Introduction and Objective: How glucose variability, sleep, physical activity modify risk of impaired awareness of hypoglycemia in T1D is unclear. We investigated associations between prior week CGM and actigraphy with epinephrine and symptom responses to recurrent hypoglycemia (HG) in aware participants with T1D. Methods: Data were pooled from 2 studies (N=60 T1D, 15 participated in both; age 29 ± 8 yrs, 37 female, A1c 7 ± 1, duration 16 ± 7 yrs, HbA1c <8.5, aware on the Clarke & Gold questionnaires). Participants wore CGM and actigraphs the week before undergoing 3 (study 1) or 4 (study 2) hyperinsulinemic clamps over 2 days (target glucose=50mg/dL). Epinephrine and symptoms were collected during the final 30 min of first (FC) and last (LC) clamps and their associations with CGM and actigraphy assessed in R, adjusting for multiple testing. Results: Epinephrine was 204±21 pg/ml (range 47-836) and symptom score was 24±1 (range 4-46) in FC. CGM derived CV, ADRRlow, LBGI, and % readings <54mg/l were associated with epinephrine at both clamps, with stronger associations at LC (Fig. 1). Daily MVPA was associated with adrenergic symptoms at LC. No other associations were observed. Conclusion: HG exposure experienced within 1 week of a HG clamp study is associated with reduced counterregulation in aware T1D. HG responses are further reduced with repeated HG exposure. Prior week moderate-vigorous activity lowers adrenergic symptoms after recurrent HG. Disclosure E. Seaquist: Advisory Panel; Current; Vertex Pharmaceuticals Incorporated, Zucara Therapeutics. A. Kumar: None. L. Zhang: None. B. Strong: None. L. Eberly: None. A. Moheet: None. G. Oz: Research Support; Ended; Biogen. Consultant; Current; Servier Laboratories. Advisory Panel; Current; BrainSpec. Funding R01 NS035192 (ERS, GÖ), NIH P41 EB027061, P30 NS076408, S10OD017974 from the National Institutes of Health.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
1350-P: Impact of Glycemia, Sleep, Physical Activity on Hypoglycemia Counterregulation in Type 1 Diabetes
Date Crossref
05/06/2026
Éditeur
American Diabetes Association
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Diabetes Management and ResearchDiabetes and associated disordersDiabetes Management and Education

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.